The role of A011 in mediating autophagy and apoptosis through the disruption of the PI3K/AKT/mTOR pathway highlights its potential as a therapeutic agent for breast cancer, emphasizing the importance of targeting autophagy mechanisms. This evidence concerns the gene PIK3CB and breast carcinoma.